V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230000770 | 230001665 | 0 | 57.8 | Adjuvant (A) | null | 2017-04-29 | CAPECITABINE + OXALIPLATIN | N | N | 230013372 | AML19 TRIAL |
| 230000771 | 230000452 | 1.69 | 101 | Adjuvant (A) | 2018-06-11 | 2018-07-02 | Capecitabine | N | N | 230013389 | CISPLATIN + GEMCITABINE |
| 230000772 | 230000452 | null | null | Palliative (P) | 2016-01-13 | 2016-01-14 | CARBOPLATIN + EPIRUBICIN | N | null | 230013389 | GEMCITABINE |
| 230000773 | 230000452 | 1.65 | 61 | Adjuvant (A) | 2013-05-09 | 2013-05-22 | ESPAC-4 TRIAL | 02 | N | 230013389 | CAPECITABINE + MITOMYCIN + RT |
| 230000774 | 230000453 | 1.55 | 65 | Adjuvant (A) | 2017-10-24 | 2017-10-24 | Fluorouricil + Folonic Acid (MdG) | N | N | 230013454 | CARBOPLATIN + PEMETREXED |
| 230000775 | 230000454 | 1.55 | 57 | Palliative (P) | 2016-12-09 | 2016-12-09 | Capecitabine | N | N | 230013480 | OXALIPLATIN + MDG |
| 230000776 | 230000454 | 1.7 | 154 | Adjuvant (A) | 2015-06-23 | 2015-07-17 | Capecitabine + Oxaliplatin 21day | N | N | 230013480 | CAPECITABINE + RT |
| 230000777 | 230000454 | 1.74 | 77.1 | Palliative (P) | 2016-10-29 | 2016-10-29 | Capecitabine + Oxaliplatin 21day | 02 | Y | 230013480 | CISPLATIN + RT |
| 230000778 | 230000455 | null | null | Palliative (P) | 2017-08-31 | 2017-08-31 | Fluorouricil + Folonic Acid (MdG) | 02 | null | 230013506 | CARBOPLATIN + EPIRUBICIN |
| 230000779 | 230000456 | null | null | Palliative (P) | 2017-01-29 | 2017-01-31 | Oxaliplatin + Modified de Gramont | null | N | 230013526 | CARBOPLATIN + PEMETREXED |
| 230000780 | 230000457 | 1.57 | 70 | Adjuvant (A) | 2015-11-28 | 2015-11-28 | Sorafenib | N | Y | 230013531 | CTD |
| 230000781 | 230000458 | 1.79 | 80 | Not known (9) | 2015-07-19 | 2015-08-11 | Capecitabine 35days + RT | N | N | 230013550 | AZACITIDINE |
| 230000782 | 230000459 | null | null | Palliative (P) | 2017-01-25 | 2017-02-14 | CAP + RT | 2 | N | 230013554 | RITUXIMAB |
| 230000783 | 230000460 | 1.84 | 88.5 | Palliative (P) | 2017-08-11 | 2017-09-01 | Cisplatin | null | N | 230013591 | CISPLATIN + PACLITAXEL |
| 230000784 | 230000461 | 1.66 | 66 | Palliative (P) | 2018-02-22 | 2018-04-20 | CAPECITABINE + OXALIPLATIN | N | N | 230013595 | OXALIPLATIN + MDG |
| 230000785 | 230001224 | 1.67 | 88.6 | Curative (C) | 2017-07-13 | 2017-08-04 | Pazopanib | N | N | 230013618 | SORAFENIB |
| 230000786 | 230000462 | 1.55 | 108.3 | Adjuvant (A) | 2018-07-27 | 2018-08-03 | Oxaliplatin + Modified de Gramont | N | null | 230013630 | SORAFENIB |
| 230000787 | 230000463 | 1.76 | 63.6 | Palliative (P) | 2016-10-14 | 2016-10-24 | Fluorouracil+Mitomycin+RT (Bladder) | N | N | 230013688 | OXALIPLATIN + MDG |
| 230000788 | 230000464 | 1.58 | null | Palliative (P) | 2018-09-01 | 2018-09-03 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | N | 230013700 | DOCETAXEL |
| 230000789 | 230000464 | 1.6 | 42.799 | Adjuvant (A) | 2017-01-25 | 2017-02-08 | Capecitabine + Oxaliplatin 21day | N | N | 230013700 | CYCLO + DOCETAXEL + TRASTUZUMAB |
| 230000790 | 230000465 | 1.66 | 90.3 | Palliative (P) | 2018-04-07 | 2018-04-22 | Fluorouracil + Folinic Acid Weekly | 02 | null | 230013734 | SORAFENIB |
| 230000791 | 230000466 | 1.68 | 67.4 | Palliative (P) | 2016-07-03 | 2016-07-21 | BOSUTINIB | N | N | 230013735 | CARBOPLATIN + ETOPOSIDE |
| 230000792 | 230001226 | 1.64 | 72 | null | null | 2018-08-24 | Capecitabine | N | null | 230013740 | VANDETANIB |
| 230000793 | 230000467 | 1.62 | 56 | Adjuvant (A) | 2016-11-21 | 2016-12-06 | Capecitabine + Oxaliplatin 21day | N | N | 230013754 | CISPLATIN + VINORELBINE |
| 230000794 | 230000468 | 1.76 | 81.8 | Palliative (P) | 2015-05-05 | 2015-05-17 | CAPECITABINE + CISPLATIN + EPIRUBICIN | 1 | N | 230013769 | CAPECITABINE + RT |
| 230000795 | 230000469 | 1.65 | null | Palliative (P) | 2017-08-27 | 2017-09-07 | Cape +Cetuximab +Oxalip (3 wk) Load | 02 | N | 230013774 | CISPLATIN + DOXORUBICIN |
| 230000796 | 230000470 | 1.65 | 45.4 | Palliative (P) | 2013-08-09 | 2013-09-18 | CAPECITABINE + OXALIPLATIN | N | N | 230013804 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 230000797 | 230000471 | 1.68 | null | Curative (C) | 2017-01-23 | 2017-02-03 | FLUOROURACIL + MITOMYCIN | N | Y | 230013808 | CAPECITABINE + OXALIPLATIN |
| 230000798 | 230000472 | 1.67 | 77 | Adjuvant (A) | 2017-05-04 | 2017-05-17 | CVP R | N | N | 230013831 | SORAFENIB |
| 230000799 | 230000472 | 1.7 | 95.5 | Adjuvant (A) | 2018-06-30 | 2018-07-01 | CAPECITABINE + MITOMYCIN + RT | 2 | N | 230013831 | CISPLATIN + RT |
| 230000800 | 230000473 | null | 50.9 | Adjuvant (A) | 2016-05-01 | 2016-05-08 | CAPECITABINE + OXALIPLATIN | N | N | 230013845 | SORAFENIB |
| 230000801 | 230001228 | 1.61 | 48.2 | Curative (C) | 2018-12-26 | 2018-12-27 | Trial Unspecified | 02 | null | 230013848 | CHOP R |
| 230000802 | 230001228 | 1.55 | 0 | Palliative (P) | 2019-01-07 | 2019-01-08 | Irinotecan + Modified De Gramont | N | N | 230013848 | CHOP R |
| 230000803 | 230001228 | 1.76 | 80.8 | Curative (C) | 2016-08-23 | 2016-08-23 | Capecitabine + Oxaliplatin 21day | N | N | 230013848 | SORAFENIB |
| 230000804 | 230000474 | 1.68 | null | Adjuvant (A) | 2017-01-27 | 2017-02-10 | Capecitabine + Oxaliplatin 14day | N | null | 230013955 | CAPECITABINE + MITOMYCIN |
| 230000805 | 230000475 | 1.75 | 97.6 | Palliative (P) | 2016-02-18 | 2016-02-21 | Carboplatin + Vinorelbine Oral | 02 | N | 230014049 | SORAFENIB |
| 230000806 | 230000476 | 1.7 | null | Palliative (P) | 2018-01-15 | 2018-02-05 | Oxaliplatin + Modified de Gramont | N | null | 230014063 | BENDAMUSTINE + RITUXIMAB |
| 230000807 | 230000476 | 1.77 | 63.5 | Adjuvant (A) | 2016-04-21 | 2017-08-17 | Capecitabine 35days + RT | null | N | 230014063 | CARBOPLATIN |
| 230000808 | 230000477 | 1.72 | 131 | Adjuvant (A) | 2015-02-07 | 2015-02-13 | Capecitabine 35days + RT | N | N | 230014109 | CARBOPLATIN + PACLITAXEL |
| 230000809 | 230000478 | 1.82 | 75 | null | 2017-01-28 | 2017-01-28 | Cisplatin + Doxorubicin | 2 | null | 230014117 | FEC |
| 230000810 | 230001230 | 1.66 | 61.7 | null | 2017-07-10 | 2017-07-13 | Cetuximab + FOLFIRI cycle1 | 02 | null | 230014140 | CARBOPLATIN + PACLITAXEL |
| 230000811 | 230001230 | 1.55 | 72 | Disease modification (D) | 2017-01-31 | 2017-02-01 | Capecitabine + Oxaliplatin 21day | 2 | N | 230014140 | OXALIPLATIN + MDG |
| 230000812 | 230000479 | 1.85 | 92.4 | Palliative (P) | 2015-10-30 | 2015-11-06 | Oxaliplatin + Modified de Gramont | N | N | 230014179 | CARBOPLATIN + PEMETREXED |
| 230000813 | 230000480 | 1.6 | 97.8 | Curative (C) | 2014-10-03 | 2014-10-03 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | null | 230014209 | CISPLATIN + RT |
| 230000814 | 230000481 | 1.49 | 85.7 | null | 2017-12-09 | 2018-01-04 | Capecitabine 35days + RT | N | null | 230014215 | FEC |
| 230000815 | 230000481 | 1.56 | 74.8 | Palliative (P) | 2016-07-03 | 2016-07-31 | CAPECITABINE + OXALIPLATIN | N | N | 230014215 | CISPLATIN + DOXORUBICIN |
| 230000816 | 230000482 | 1.6 | null | Adjuvant (A) | 2013-06-15 | 2013-06-22 | Oxaliplatin + Modified de Gramont | 99 | N | 230014255 | GEMCARBO |
| 230000817 | 230000483 | 1.7 | 70.4 | Curative (C) | 2014-06-26 | 2014-07-12 | CARBOPLATIN + FLUOROURACIL | N | N | 230014289 | RITUXIMAB |
| 230000818 | 230000483 | 1.6 | 130.7 | Not known (9) | null | 2017-02-03 | Oxaliplatin + Modified de Gramont | N | N | 230014289 | OLAPARIB |
| 230000819 | 230000484 | 1.66 | null | Adjuvant (A) | null | 2012-10-31 | CISPLATIN + RT | N | Y | 230014380 | PEMBROLIZUMAB |